Development and In Vitro Evaluation of Near-Infrared Dye-Conjugated Pullulan-Based Nanogels for M2 Macrophage-Targeted pH-Responsive Theranostic Agents
Aug 2026· Journal of Nanotheranostics· Vol 7, pp. 20· 0 citations· 39 references
TL;DR
Findings support the use of PMID nanogel as M2 macrophage-targeted PA contrast agents and pH-responsive drug carriers with the potential to deplete immunosuppressive macrophages, modulate cold tumor microenvironments, and improve precision cancer theranostics.
Abstract
Immunotherapy can reduce treatment-related side effects but shows limited efficacy in “cold tumors,” whose immunosuppressive tumor immune microenvironment is characterized by abundant M2 macrophages and poor T cell infiltration. Because biopsy-based qualitative assessment of the tumor microenvironment is invasive and conventional imaging lacks functional information, this study aimed to develop an M2 macrophage-targeted theranostic agent enabling non-invasive photoacoustic (PA) imaging and pH-triggered cytotoxicity. A pullulan-based nanogel conjugated with mannose and near-infrared dye (IR-820) was further functionalized with the pH-responsive doxorubicin (DOX) prodrug, Aldoxorubicin, to develop Pullulan-mannose-IR820-Aldoxorubicin (PMID) nanogel. PMID was successfully synthesized, and the resulting self-assembled nanogels (<100 nm) exhibited a highly negative ζ-potential, near-infrared absorption peaks at 780 and 850 nm, and PA contrast comparable to IR-820 at 850 nm excitation. Dialysis studies demonstrated suppressed drug release at neutral pH (~20%) but accelerated release under acidic conditions, reaching ~80% within 48 h at pH 5.5, consistent with hydrazone hydrolysis and supporting tumor/lysosome-activated delivery. In RAW264.7 macrophages, PMID nanogel showed preferential uptake by M2-poralized versus M1-polarized macrophages, outperforming non-mannosylated PID nanogel and IR-820, and produced the strongest PA signal in M2 macrophage pellets. PMID nanogel also induced the highest concentration-dependent cytotoxicity in M2 macrophages, and microscopy indicated lysosomal accumulation of the nanogel with partial nuclear localization of released DOX. These findings support the use of PMID nanogel as M2 macrophage-targeted PA contrast agents and pH-responsive drug carriers with the potential to deplete immunosuppressive macrophages, modulate cold tumor microenvironments, and improve precision cancer theranostics.
A smart phototheranostic nanoagent that simultaneously combined active tumor targeting and TME response for highly tumor-specific multimodal imaging-guided synergistic PDT/PTT/CDT, providing a simple and universal strategy for enhancing the precision and efficiency of phototheranostics.
Gui-Ce Ding, Yi-Ling Wang, Yan-Qin Huang et al.· ACS Applied Materials and In...· 0 citations
Breast cancer, particularly triple-negative breast cancer (TNBC), remains a major therapeutic challenge because of aggressive tumor progression, systemic toxicity, rapid clearance of conventional chemotherapeutics, and multidrug resistance. The present study developed a biomimetic, redox-responsive liposomal theranosti...
M. B. Duza· Natural Resources for Human...· 0 citations
This study engineered a tumor microenvironment (TME) dual-responsive aggregation-induced emission (AIE) micellar system (HA-SS-TPEDCH-Th) to achieve receptor-guided specific bioimaging and localized photodynamic ablation and highlights the translational promise of actively targeted, dual-locked AIE micelles as a highly...
Lei Chen, Shan-Shan Jiang, Jin-Hui Wang et al.· Spectrochimica Acta Part A -...· 0 citations
Protein delivery nanosystems must balance stable loading, barrier navigation, and targeted, controlled release. Herein, a pH/ROS dual-responsive nanogel (PRNG) was constructed by forming dynamic boronic ester crosslinkers between PEGylated hyaluronic acid bearing diethylenetriamine-grafted-catechol groups (PEG-HA-Dien-...
A multifunctional nanodrug system, CuV/DTPA@Catalase/99mTc-5FU, engineered for enhanced anticancer efficacy and imaging that can overcome limitations of conventional chemotherapy by regulating the NF-κB pathway and enabling precise drug delivery is presented.
Iqra Iqbal, Ummama Saeed, B. Fatima et al.· International Journal of Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.